AbstractObjective To investigate postoperative recurrent pattern of the thoracic esophageal squamous cell carcinoma (TESCC),aiming to provide a basis for the delineation of postoperative radiotherapy volume for TESCC. Methods Clinical data of 66 TESCC patients who recurred after the radical esophagectomy in Zhongnan Hospital of Wuhan University from 2011 to 2017 were retrospectively analyzed. According to the AJCC 8th edition-defined classification of esophageal carcinoma, regional lymph node stations 1 to 8M were defined as the upper-middle mediastinum region (UMMR),and stations 8Lo,9 and 15 were defined as the inferior mediastinum region (IMR),stations 16 to 20 were regarded as the upper abdominal lymph node region (UAR). Results Among all 66 patients,41 cases (62%) experienced loco-regional recurrence alone,25 cases (38%) presented with distant metastasis alone. A total of 54 patients with 148 lymph node recurred after treatment. The highest risk region of lymph node recurrence was UMMR (118/148,80%),after that,followed by UAR (24/148,17%). With regard to 9 cases of UAR, 6 patients had lower TESCC,and 8 patients (89%) were graded as ≥ pathological stage Ⅲ. Conclusions The highest risk region of lymph node recurrence is UMMR in TESCC patients undergoing radical esophagectomy, which should be considered as the target volume in postoperative radiotherapy. For patients with lower TESCC ≥ pathological stage Ⅲ,UAR might be the target volume with cautions. Anastomosis and IMR are probably not the routine treatment volumes.
Li Chunyang,Yu Jing,Shen Jiuling et al. Postoperative recurrent pattern and the lymph node metastatic stations of the thoracic esophageal squamous cell carcinoma[J]. Chinese Journal of Radiation Oncology, 2019, 28(9): 673-676.
Li Chunyang,Yu Jing,Shen Jiuling et al. Postoperative recurrent pattern and the lymph node metastatic stations of the thoracic esophageal squamous cell carcinoma[J]. Chinese Journal of Radiation Oncology, 2019, 28(9): 673-676.
[1] Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(1):115-132. DOI:10.3322/caac.21338. [2] Torre LA,Bray F,Siegel R,et al. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(1):87-108. DOI:10.3322/caac.21262. [3] Zhang Y. Epidemiology of esophageal cancer[J]. World J Gastroenterol,2013,19(34):5598-5606. DOI:10.3748/wjg.v19.i34.5598. [4] Hsu PK,Chen HS,Huang CS,et al. Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma[J]. Br J Surg,2017,104(1):90-97. DOI:10.1002/bjs.10334. [5] Chen J,Pan J,Zheng X,et al. Number and location of positive nodes,postoperative radiotherapy,and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys,2012,82(3):475-482. DOI:10.1016/j.ijrobp.2010.08.037. [6] Worni M,Martin J,Gloor B,et al. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008[J]. J Am Coll Surg,2012,215(4):643-651. DOI:10.1016/j.jamcollsurg. 2012.07.006. [7] Rice TW,Ishwaran H,Ferguson MK,et al. Cancer of the esophagus and esophagogastric junction:an eighth edition staging primer[J]. J Thorac Oncol,2017,12(1):36-42. DOI:10.1016/j.jtho.2016.10.016. [8] Mariette C,Balon JM,Piessen G,et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease[J]. Cancer,2003,97(7):1616-1623. DOI:10.1002/cncr.11228. [9] Cai WJ,Xin PL. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy[J]. Radiother Oncol,2010,96(1):104-107. DOI:10.1016/j.radonc.2010.04.029. [10] Yamashita K,Watanabe M,Mine S,et al. Patterns and outcomes of recurrent esophageal cancer after curative esophagectomy[J]. World J Surg,2017,41(9):2337-2344. DOI:10.1007/s00268-017-4024-5. [11] Wang X,Luo Y,Li M,et al. Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus:implications for the clinical target volume design of postoperative radiotherapy[J]. OncoTarg Ther,2016,9:6021-6027. DOI:10.2147/OTT. S116348.
2019, Vol. 28 
